Clinical Approach to Heavy Postpartum Bleeding
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of heavy postpartum bleeding
Postpartum hemorrhage (PPH) remains the leading cause of maternal mortality worldwide, responsible for approximately 25% of all maternal deaths globally. In developed countries, PPH complicates 3-5% of all deliveries, while in resource-limited settings, the incidence rises to 10-30%. Despite advances in obstetric care, PPH accounts for nearly 140,000 maternal deaths annually—one death approximately every four minutes. Early recognition and systematic management are critical, as the majority of PPH-related deaths are preventable with timely intervention.
Definition
Traditional definition: Blood loss of ≥500 mL after vaginal delivery or ≥1000 mL after cesarean delivery within 24 hours of birth.
Revised definition (ACOG 2017): Cumulative blood loss ≥1000 mL or bleeding associated with signs or symptoms of hypovolemia within 24 hours of delivery, regardless of route of delivery.
Massive PPH: Blood loss ≥2000 mL, need for transfusion of ≥4 units of packed red blood cells, or hemodynamic instability requiring intervention.
Classification by Timing
| Category | Timing | Common Causes | Clinical Significance |
|---|---|---|---|
| Primary (Early) PPH | Within 24 hours of delivery | Uterine atony (70-80%), genital tract trauma, retained placental tissue, coagulopathy | Most common; requires immediate recognition and intervention; majority of PPH-related mortality occurs here |
| Secondary (Late) PPH | 24 hours to 12 weeks postpartum | Retained products of conception, endometritis, subinvolution of placental site, inherited coagulation defects | Less common (0.5-2%); often presents after hospital discharge; may indicate infection or retained tissue |
Classification by Severity
| Class | Blood Loss | % Blood Volume | Clinical Signs |
|---|---|---|---|
| Class I (Compensated) | 500-1000 mL | 10-15% | Palpitations, dizziness, tachycardia (100-120 bpm), normal blood pressure, normal capillary refill |
| Class II (Mild) | 1000-1500 mL | 15-25% | Weakness, sweating, tachycardia (120-140 bpm), narrowed pulse pressure, delayed capillary refill |
| Class III (Moderate) | 1500-2000 mL | 25-35% | Restlessness, pallor, oliguria, tachycardia (>140 bpm), hypotension (systolic 70-80 mmHg), cold extremities |
| Class IV (Severe) | >2000 mL | >35% | Collapse, air hunger, anuria, profound hypotension (systolic <70 mmHg), altered consciousness, cardiovascular collapse |
Classification by Etiology: The “Four T’s”
Tone (70-80%)
Uterine atony — failure of the uterus to contract adequately after delivery. This is the most common cause of PPH. Risk factors include overdistension (multiple gestation, polyhydramnios, macrosomia), prolonged labor, rapid labor, chorioamnionitis, and uterine relaxants.
Trauma (10-20%)
Genital tract injury — includes lacerations of the cervix, vagina, or perineum; uterine rupture; and uterine inversion. Associated with instrumental delivery, precipitous labor, episiotomy extension, and previous uterine surgery.
Tissue (5-10%)
Retained placental tissue — includes retained placenta, retained placental fragments (cotyledons), abnormal placentation (accreta spectrum), and retained blood clots. Prevents effective uterine contraction.
Thrombin (1-3%)
Coagulation disorders — includes pre-existing conditions (von Willebrand disease, hemophilia carriers), acquired coagulopathies (disseminated intravascular coagulation, dilutional coagulopathy), and anticoagulant use.
Risk Factors by Category
| Category | Risk Factors | Mechanism |
|---|---|---|
| Antepartum | Previous PPH, placenta previa, placenta accreta spectrum, multiple gestation, polyhydramnios, grand multiparity, fibroids, obesity, advanced maternal age | Uterine overdistension, abnormal placentation, impaired contractility |
| Intrapartum | Prolonged labor, augmented labor, precipitous labor, chorioamnionitis, operative vaginal delivery, cesarean delivery (especially emergency), general anesthesia | Uterine fatigue, infection, trauma |
| Postpartum | Retained placenta, uterine inversion, genital tract lacerations, coagulopathy | Mechanical obstruction, trauma, impaired hemostasis |
Key Concept — The Four T’s: The mnemonic “Four T’s” (Tone, Trauma, Tissue, Thrombin) accounts for virtually all causes of PPH. Uterine atony (Tone) is responsible for 70-80% of cases and should always be the first consideration. However, approximately 40% of PPH cases occur in women with no identifiable risk factors — therefore, every delivery team must be prepared for PPH.
Physiological Adaptation in Pregnancy
During pregnancy, blood volume increases by 40-50% (1500-2000 mL), and cardiac output increases by 30-50%. This physiological hypervolemia allows healthy pregnant women to tolerate blood loss that would cause significant symptoms in non-pregnant individuals. Consequently, vital sign changes may be delayed until substantial blood loss has occurred, making early recognition challenging. A “normal” blood pressure in an actively bleeding postpartum patient should not provide false reassurance.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of postpartum hemostasis and hemorrhage
Understanding normal postpartum hemostasis is essential for comprehending how PPH develops and why specific interventions are effective. At term, uterine blood flow reaches approximately 500-800 mL per minute—representing 10-15% of total cardiac output—flowing through the spiral arteries that supply the placental bed. After placental separation, rapid and effective hemostasis must occur to prevent exsanguination.
The Three Pillars of Postpartum Hemostasis
| Component | Mechanism | Clinical Relevance |
|---|---|---|
| 1. Myometrial Contraction (“Living Ligatures”) | Following placental separation, the interlacing myometrial fibers contract around the spiral arteries that traverse the uterine wall, mechanically compressing and occluding them | This is the PRIMARY mechanism of hemostasis; uterotonic medications target this mechanism; a well-contracted uterus feels firm and “globular” at or below the umbilicus |
| 2. Decidual Hemostasis | Local decidual factors promote vasoconstriction and platelet aggregation at the placental site | Explains why retained tissue prevents hemostasis—the decidua cannot function normally with tissue covering the placental bed |
| 3. Systemic Coagulation | Pregnancy is a hypercoagulable state with increased fibrinogen (400-600 mg/dL at term), increased factors VII, VIII, X, and decreased fibrinolysis | Coagulation cascade forms stable clots at bleeding sites; disruption (DIC, dilution, consumption) leads to ongoing hemorrhage despite adequate tone |
Mechanism of Uterine Atony
Why does the uterus fail to contract?
Myometrial contraction requires coordinated calcium-mediated actin-myosin interaction. Any factor that disrupts this process leads to atony:
- Uterine overdistension: Stretching of myometrial fibers beyond optimal length impairs contractile efficiency (multiple gestation, polyhydramnios, macrosomia)
- Myometrial fatigue: Prolonged labor depletes ATP stores and glycogen reserves needed for sustained contraction
- Infection: Chorioamnionitis releases inflammatory mediators that interfere with myometrial contractility
- Pharmacological relaxation: Tocolytics, magnesium sulfate, volatile anesthetics, and calcium channel blockers directly inhibit contraction
- Structural abnormalities: Fibroids distort the myometrium and prevent uniform contraction
Pathophysiology of Each “T”
| Etiology | Pathophysiological Mechanism | Clinical Presentation | Treatment Rationale |
|---|---|---|---|
| Tone (Uterine Atony) | Failure of myometrial contraction → spiral arteries remain patent → continuous bleeding from placental site (500-800 mL/min potential) | Soft, “boggy” uterus above umbilicus; heavy vaginal bleeding; uterus may contain large blood clots | Uterotonics restore myometrial contraction; bimanual compression provides mechanical hemostasis; uterine massage expels clots |
| Trauma (Genital Tract Injury) | Direct vascular injury to cervix, vagina, perineum, or uterus → arterial or venous bleeding from laceration sites; uterine rupture disrupts uterine wall integrity | Bright red bleeding despite firm uterus; visible laceration on inspection; vulvar or vaginal hematoma; signs of intra-abdominal bleeding (rupture) | Surgical repair restores vascular integrity; pressure and packing provide temporary tamponade; laparotomy required for rupture |
| Tissue (Retained Placenta) | Retained tissue prevents complete uterine contraction and covers decidual hemostatic mechanisms → persistent bleeding; abnormal placentation (accreta) invades myometrium → cannot separate normally | Incomplete placenta on inspection; uterus fails to contract fully; variable bleeding; may have prolonged third stage | Manual removal allows uterine contraction; curettage removes fragments; hysterectomy may be required for accreta spectrum |
| Thrombin (Coagulopathy) | Impaired clot formation (factor deficiency) or clot breakdown (hyperfibrinolysis) → bleeding continues despite normal tone; consumption of factors (DIC) creates vicious cycle | Diffuse oozing from IV sites, surgical sites, mucous membranes; blood fails to clot; continued bleeding despite firm uterus and no visible trauma | Replace deficient factors (FFP, cryoprecipitate, platelets); tranexamic acid inhibits fibrinolysis; treat underlying cause (sepsis, abruption) |
Uterotonic Agents: Receptor Targets and Mechanisms
Oxytocin Receptors
Location: Myometrial cell membranes (density increases dramatically at term)
Mechanism: G-protein coupled receptor → phospholipase C activation → increased intracellular calcium → myometrial contraction
Clinical relevance: First-line uterotonic; receptor downregulation occurs with prolonged oxytocin exposure (augmented labor), reducing effectiveness
Prostaglandin Receptors
Location: Myometrium (FP receptors for PGF2α, EP receptors for PGE)
Mechanism: PGF2α → direct myometrial contraction and vasoconstriction; PGE1 (misoprostol) → similar contractile effect
Clinical relevance: Second-line agents; effective when oxytocin fails; carboprost (PGF2α) contraindicated in asthma; misoprostol heat-stable and inexpensive
Adrenergic Receptors
Location: Myometrium (alpha-1 receptors) and vascular smooth muscle
Mechanism: Alpha-1 agonists (ergot alkaloids) → potent sustained myometrial contraction and vasoconstriction
Clinical relevance: Ergometrine/methylergonovine highly effective but contraindicated in hypertension and cardiac disease due to systemic vasoconstriction
Coagulation Changes in Massive PPH
| Phase | What Happens | Laboratory Findings | Clinical Implications |
|---|---|---|---|
| Early Hemorrhage | Coagulation factors consumed at bleeding site; initial hypercoagulable state may temporarily compensate | Normal or slightly prolonged PT/PTT; fibrinogen begins to fall | Early tranexamic acid (within 3 hours) reduces mortality; anticipate factor depletion |
| Dilutional Coagulopathy | Large-volume crystalloid/colloid resuscitation dilutes remaining clotting factors and platelets | Prolonged PT/PTT; fibrinogen <200 mg/dL; platelet count falling | Balanced transfusion (1:1:1 PRBC:FFP:platelets) prevents dilution; avoid crystalloid-heavy resuscitation |
| Consumptive Coagulopathy (DIC) | Widespread activation of coagulation → consumption of factors and platelets → secondary hyperfibrinolysis | Severely prolonged PT/PTT; very low fibrinogen (<100 mg/dL); thrombocytopenia; elevated D-dimer | Replace fibrinogen (cryoprecipitate) when <150-200 mg/dL; continue tranexamic acid; treat underlying cause |
| Hypothermic Coagulopathy | Core temperature <35°C impairs enzyme function in coagulation cascade | Coagulation tests performed at 37°C may underestimate in vivo dysfunction | Active warming essential; use blood warmers; warm IV fluids; increase ambient temperature |
Placenta Accreta Spectrum: Pathophysiology
| Type | Depth of Invasion | Mechanism | Clinical Consequence |
|---|---|---|---|
| Placenta Accreta | Villi attach directly to myometrium (absent decidua basalis) | Deficient decidualization (usually at previous cesarean scar) allows trophoblast to contact myometrium | Placenta fails to separate; manual removal causes massive hemorrhage |
| Placenta Increta | Villi invade into myometrium | Trophoblast penetrates deeper due to absent decidual barrier | More extensive bleeding; higher likelihood of hysterectomy |
| Placenta Percreta | Villi penetrate through myometrium to serosa (may invade bladder, bowel) | Complete penetration of uterine wall; trophoblast may invade adjacent organs | Life-threatening hemorrhage; often requires cesarean hysterectomy with multidisciplinary surgical team |
Often Overlooked: The “Bloody Vicious Cycle”
Massive hemorrhage creates a self-perpetuating cycle of worsening coagulopathy: Bleeding → Hypothermia + Acidosis + Hemodilution → Impaired coagulation → More bleeding. This “lethal triad” of hypothermia, acidosis, and coagulopathy must be aggressively prevented and treated simultaneously with surgical control of bleeding. Point-of-care coagulation testing (TEG/ROTEM) can guide targeted factor replacement faster than traditional laboratory tests.
Critical Understanding: Visual Blood Loss Estimation is Unreliable
Studies consistently demonstrate that visual estimation underestimates actual blood loss by 30-50%. Contributing factors include:
- Blood absorbed in drapes, gowns, and sponges
- Blood mixed with amniotic fluid
- Blood pooling under the patient or in bedding
- Concealed hemorrhage (broad ligament hematoma, intra-abdominal bleeding)
Quantitative blood loss (QBL) measurement using calibrated drapes and gravimetric weighing of blood-soaked materials is now recommended for all deliveries to improve early PPH recognition.
3. History Taking
A comprehensive approach to eliciting the postpartum hemorrhage history
Red Flags — Require Immediate Action
- Estimated blood loss >1000 mL — activate hemorrhage protocol
- Tachycardia >120 bpm — significant hypovolemia likely
- Hypotension (systolic <90 mmHg) — decompensated shock
- Altered mental status — severe hypovolemia or hypoxia
- Oliguria (<30 mL/hour) — inadequate organ perfusion
- Cold, clammy extremities — peripheral vasoconstriction indicating shock
- Persistent bleeding despite firm uterus — suspect trauma or coagulopathy
- Known placenta accreta spectrum — prepare for massive transfusion
- Coagulopathy (oozing from IV sites) — DIC developing
- Chest pain or dyspnea — possible amniotic fluid embolism
In the acute setting of postpartum hemorrhage, history taking must be rapid, focused, and often obtained simultaneously with resuscitation. A structured approach helps identify the underlying cause while ensuring no critical information is missed. Much relevant history may already be documented in the labor and delivery record.
Systematic History: The “BLEEDS” Approach
Use the mnemonic “BLEEDS” to ensure comprehensive and rapid history taking in postpartum hemorrhage:
- B — Blood loss assessment: How much blood has been lost? When did bleeding start? Is it continuous or intermittent? What is the character (bright red vs. dark, clots present)?
- L — Labor and delivery details: Mode of delivery? Duration of labor? Instrumentation used? Any complications during delivery? Was oxytocin used for augmentation?
- E — Expulsion of placenta: Was the placenta delivered completely? How long was the third stage? Was manual removal required? Any suspicion of retained fragments?
- E — Existing risk factors: Previous PPH? Multiple gestation? Polyhydramnios? Fibroids? Known placenta previa or accreta? Grand multiparity?
- D — Drugs and medical history: Current medications (anticoagulants, tocolytics, magnesium)? Bleeding disorders? Liver disease? Pre-eclampsia/HELLP?
- S — Signs of shock: Dizziness? Palpitations? Thirst? Confusion? Chest pain? Visual changes?
Targeted Questions by Suspected Cause (The Four T’s)
| Suspected Cause | Key Historical Features | Ask These Questions |
|---|---|---|
| Tone (Uterine Atony) | Prolonged labor, rapid labor, uterine overdistension, chorioamnionitis, oxytocin use during labor | “How long was the labor?” “Was there a fever during labor?” “Was this a large baby or twins?” “How much oxytocin was used during labor?” |
| Trauma (Genital Tract Injury) | Instrumental delivery, precipitous labor, previous cesarean section, episiotomy | “Was forceps or vacuum used?” “How quickly did the baby deliver?” “Was an episiotomy performed?” “Any history of previous cesarean sections?” |
| Tissue (Retained Products) | Prolonged third stage, manual removal of placenta, incomplete placenta on inspection, history of retained placenta | “Was the placenta delivered completely?” “How long after delivery did the placenta come out?” “Did the placenta have to be removed manually?” “Was the placenta examined and found complete?” |
| Thrombin (Coagulopathy) | Known bleeding disorder, anticoagulant use, placental abruption, severe pre-eclampsia/HELLP, intrauterine fetal demise, sepsis | “Do you have a history of bleeding problems or easy bruising?” “Are you taking any blood thinners?” “Was there any placental abruption?” “Do you have pre-eclampsia or HELLP syndrome?” |
Antepartum Risk Factor Assessment
| Risk Factor Category | Specific Factors | Key Questions |
|---|---|---|
| Previous Obstetric History | Previous PPH (strongest predictor), previous cesarean delivery, previous retained placenta, grand multiparity (≥5) | “Did you have heavy bleeding after any previous deliveries?” “How many cesarean sections have you had?” “Have you ever needed a blood transfusion after delivery?” |
| Current Pregnancy Factors | Multiple gestation, polyhydramnios, macrosomia, placenta previa, known placenta accreta spectrum | “Is this a twin or multiple pregnancy?” “Was there excess amniotic fluid?” “Where is the placenta located?” “Is there any concern about placenta growing into the uterine wall?” |
| Uterine Factors | Fibroids (especially large or multiple), uterine anomalies, previous uterine surgery | “Do you have fibroids?” “Have you had any surgery on your uterus before?” “Were any uterine abnormalities found during pregnancy?” |
| Maternal Factors | Advanced maternal age (>35), obesity (BMI >35), anemia, Asian ethnicity | “What is your age?” “What was your hemoglobin level during pregnancy?” “Were you anemic during pregnancy?” |
Medication and Medical History
Medications That Increase Bleeding Risk
- Anticoagulants — warfarin, heparin, low-molecular-weight heparin, direct oral anticoagulants
- Antiplatelet agents — aspirin (commonly used for pre-eclampsia prevention), clopidogrel
- Tocolytics — may cause uterine relaxation if recently administered
- Magnesium sulfate — used for seizure prophylaxis in pre-eclampsia; causes myometrial relaxation
- Calcium channel blockers — nifedipine used as tocolytic; inhibits uterine contraction
- Volatile anesthetics — halogenated agents cause dose-dependent uterine relaxation during general anesthesia
Medical Conditions Affecting Hemostasis
- Inherited bleeding disorders: von Willebrand disease (most common), hemophilia carriers, platelet function disorders
- Acquired coagulopathies: HELLP syndrome, acute fatty liver of pregnancy, disseminated intravascular coagulation
- Liver disease: impaired synthesis of clotting factors
- Pre-eclampsia/eclampsia: associated with HELLP, placental abruption, DIC
- Sepsis: can trigger DIC and impair coagulation
- Intrauterine fetal demise: risk of consumptive coagulopathy if prolonged retention
Critical Information from Labor and Delivery Record
Review the Chart Rapidly for These Key Elements
- Admission hemoglobin/hematocrit: baseline for comparison
- Blood type and antibody screen: essential for transfusion
- Duration of labor stages: prolonged first/second stage increases atony risk
- Oxytocin use: total dose and duration (receptor desensitization)
- Mode of delivery: cesarean, instrumental vaginal, spontaneous vaginal
- Third stage management: active vs. expectant; duration; cord traction used
- Placental examination: completeness documented; any missing cotyledons noted
- Estimated blood loss: documented EBL at delivery; any quantitative measurement
- Temperature during labor: fever suggests chorioamnionitis
- Medications given: uterotonics already administered, antibiotics, magnesium
Additional History for Secondary (Late) Postpartum Hemorrhage
| Focus Area | Key Questions | What It Suggests |
|---|---|---|
| Timing and Pattern | “When did the bleeding start?” “Has it been continuous or intermittent?” “Is it getting heavier?” | Bleeding at 1-2 weeks suggests retained products or subinvolution; later bleeding may indicate infection |
| Associated Symptoms | “Do you have fever or chills?” “Is there foul-smelling discharge?” “Do you have lower abdominal pain?” | Fever + foul discharge = endometritis; pain may indicate retained products or infection |
| Lochia Progression | “How has your bleeding changed since delivery?” “Did the bleeding seem to be decreasing and then increase again?” | Normal lochia progresses from rubra → serosa → alba; return to heavy red bleeding is abnormal |
| Breastfeeding Status | “Are you breastfeeding?” “How often?” | Breastfeeding releases oxytocin, promoting uterine involution; may be protective |
4. Physical Examination
A systematic approach to examining patients with postpartum hemorrhage
Systematic Framework: In PPH, examination must be rapid, focused, and therapeutic. The examination itself often constitutes treatment (bimanual uterine compression, identification of lacerations for repair). Use the “Outside-In” approach: start with vital signs and general assessment, then systematically examine abdomen, uterus, and genital tract.
General Inspection (30 Seconds)
- Level of consciousness: Alert and oriented? Confused or agitated (early shock)? Obtunded (severe shock)?
- Color: Pallor of conjunctivae, oral mucosa, nail beds indicates significant anemia; peripheral cyanosis indicates poor perfusion
- Respiratory pattern: Tachypnea? Air hunger? Labored breathing suggests severe hypovolemia or pulmonary edema
- Skin appearance: Diaphoresis (sweating)? Cool and clammy extremities? Mottled skin?
- Visible blood loss: Blood on bed, floor, drapes; soaked pads; clots visible
- Patient distress: Anxiety, restlessness, complaints of thirst — early signs of hypovolemia
Vital Signs — The Shock Index
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Heart Rate | Tachycardia >100 bpm; note that beta-blockers may blunt response | Often the FIRST vital sign to change; tachycardia >120 bpm suggests >1500 mL blood loss |
| Blood Pressure | Hypotension (systolic <90 mmHg); narrowed pulse pressure | May remain normal until 25-30% blood volume lost due to pregnancy hypervolemia; late sign of decompensation |
| Shock Index (HR/SBP) | Normal in pregnancy: 0.7-0.9; Abnormal: >0.9; Concerning: >1.0 | More sensitive than individual vital signs; SI >1.0 associated with need for massive transfusion and ICU admission |
| Respiratory Rate | Tachypnea >20 breaths/min | Compensation for metabolic acidosis from tissue hypoperfusion |
| Oxygen Saturation | SpO2 <95% on room air | May be maintained despite severe anemia; desaturation is a late and ominous sign |
| Temperature | Fever >38°C or hypothermia <36°C | Fever suggests chorioamnionitis/endometritis; hypothermia indicates severe shock or massive transfusion |
| Urine Output | Oliguria <0.5 mL/kg/hour or <30 mL/hour | Reflects renal perfusion; requires Foley catheter for accurate monitoring |
The Shock Index: A Critical Tool
The Shock Index (SI) = Heart Rate ÷ Systolic Blood Pressure is more sensitive than individual vital signs for detecting early hemorrhagic shock. In pregnancy, normal SI is 0.7-0.9. A SI >0.9 suggests significant blood loss, and SI >1.0 is associated with need for blood transfusion, ICU admission, and increased morbidity. Calculate the Shock Index early and serially.
Abdominal Examination
Uterine Assessment (The Most Critical Step)
| Finding | Description | Clinical Interpretation |
|---|---|---|
| Uterine Fundal Height | Palpate fundus: should be at or below umbilicus immediately postpartum | Fundus above umbilicus or deviated suggests atony, distension with blood/clots, or full bladder |
| Uterine Tone | Firm/contracted: feels like a hard grapefruit Soft/boggy: poorly defined, doughy, difficult to palpate borders | Boggy uterus = uterine atony (most common cause of PPH); firm uterus with ongoing bleeding = look for trauma or coagulopathy |
| Uterine Tenderness | Significant tenderness on palpation | May indicate endometritis, uterine rupture, or broad ligament hematoma |
| Bladder Distension | Palpable suprapubic fullness; inability to palpate uterus clearly | Full bladder prevents uterine contraction; catheterize immediately |
Abdominal Inspection and Palpation
- Cesarean incision (if applicable): Intact? Signs of dehiscence? Hematoma formation?
- Abdominal distension: Increasing distension may indicate intra-abdominal bleeding
- Peritoneal signs: Guarding, rigidity, rebound tenderness suggest intraperitoneal hemorrhage (uterine rupture)
- Bowel sounds: May be absent in peritonitis or ileus from significant hemorrhage
Genital Tract Examination
Systematic Inspection is Essential
If the uterus is well-contracted but bleeding continues, genital tract trauma must be systematically excluded. Adequate visualization requires: good lighting, proper positioning, assistance for retraction, and often anesthesia/analgesia for thorough examination. Do not attribute ongoing bleeding to “oozing” without complete inspection.
External Genitalia
- Vulvar hematoma: Rapidly expanding, tense, painful swelling — may contain significant blood volume
- Perineal lacerations: First through fourth degree; assess extent and active bleeding
- Episiotomy site: Bleeding from edges? Extension? Hematoma formation?
Vaginal Examination
- Vaginal lacerations: May extend high into vaginal fornices; require speculum examination
- Vaginal wall hematoma: Paravaginal or pararectal; may be occult
- Blood clots: Evacuate clots to assess ongoing bleeding rate
- Cervical inspection: Cervical lacerations often at 3 and 9 o’clock positions; may extend to lower uterine segment
Uterine Cavity Assessment
- Manual exploration: Insert hand into uterine cavity to assess for retained products, uterine rupture, or uterine inversion
- Retained placental tissue: Soft, irregular tissue adherent to uterine wall
- Uterine rupture: Palpable defect in uterine wall; fingers may pass through defect
- Uterine inversion: Fundus not palpable abdominally; may feel as mass in vagina or at introitus
Specific Findings by Etiology
| Condition | Abdominal Findings | Genital Tract Findings | Other Findings |
|---|---|---|---|
| Uterine Atony | Soft, boggy uterus; fundus above umbilicus; may contain clots | Heavy vaginal bleeding; large clots expelled with massage | Responds to bimanual compression and uterotonics |
| Genital Tract Laceration | Firm, well-contracted uterus | Bright red bleeding; visible laceration on inspection; may require speculum/retractors | Bleeding often arterial (pulsatile); continues despite good uterine tone |
| Retained Placental Tissue | Uterus may be partially contracted; may feel bulky | Variable bleeding; tissue palpable on manual exploration | Incomplete placenta on prior inspection; prolonged third stage history |
| Uterine Rupture | Tender abdomen; may have peritoneal signs; fetal parts may be palpable | Palpable defect in uterine wall on exploration; variable vaginal bleeding | Often preceded by abnormal fetal heart tracing; sudden pain; shock out of proportion to visible bleeding |
| Uterine Inversion | Fundus not palpable abdominally; may feel “dimple” or crater | Fundus visible at introitus or palpable in vagina; placenta may still be attached | Severe pain; vasovagal response common; neurogenic shock may occur |
| Coagulopathy | Uterus may be firm (other causes addressed) | Diffuse oozing; bleeding from puncture sites; failure of blood to clot | Bleeding from IV sites, gums, mucous membranes; petechiae; ecchymoses |
| Broad Ligament Hematoma | Unilateral lower abdominal tenderness; palpable mass | Lateral vaginal wall displacement; cervix deviated | Shock out of proportion to visible blood loss (concealed hemorrhage) |
Assessment of Other Systems
Cardiovascular
- Peripheral pulses: Weak, thready pulses indicate hypovolemia
- Capillary refill: >3 seconds suggests poor perfusion
- Jugular venous pressure: Flat neck veins in supine patient indicates volume depletion
- Heart sounds: Tachycardia; gallop rhythm in severe cases
Extremities and Skin
- Temperature: Cool extremities indicate peripheral vasoconstriction
- Color: Pallor, mottling, peripheral cyanosis
- IV access sites: Oozing suggests coagulopathy
- Edema: May mask signs of blood loss
Bimanual Uterine Compression (Diagnostic and Therapeutic)
Technique for Bimanual Compression
This maneuver serves both diagnostic and therapeutic purposes:
- Empty the bladder (insert Foley catheter)
- Insert one hand into the vagina, forming a fist against the anterior uterine wall
- Place the other hand on the abdomen behind the uterus
- Compress the uterus firmly between both hands
- Maintain compression while uterotonics are administered
- Assess response: if bleeding stops with compression, atony is confirmed; if bleeding continues despite compression and firm uterus, suspect other causes
Important Teaching Point
The “Firm Uterus with Ongoing Bleeding” Scenario: When the uterus is well-contracted but bleeding persists, the cause is NOT atony. You must systematically consider: (1) Genital tract trauma — perform thorough inspection; (2) Retained tissue — manual exploration or ultrasound; (3) Coagulopathy — check for diffuse oozing, send coagulation studies; (4) Concealed hemorrhage — broad ligament hematoma, intra-abdominal bleeding. Do not repeatedly massage a firm uterus or give additional uterotonics when atony has been excluded.
5. Differential Diagnosis
Systematic approach organized by probability, timing, and the Four T’s framework
The differential diagnosis of postpartum hemorrhage is best organized using the “Four T’s” mnemonic (Tone, Trauma, Tissue, Thrombin), which encompasses virtually all causes. Understanding the relative frequency of each category allows for efficient, systematic evaluation while ensuring life-threatening causes are not missed.
Primary (Early) Postpartum Hemorrhage (Within 24 Hours)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (70-80%) | Uterine Atony | Soft, boggy uterus; fundus above umbilicus; heavy bleeding with clots; responds to massage and uterotonics | Failure to respond to first-line uterotonics; shock out of proportion to visible blood loss |
| LESS COMMON (10-20%) | Cervical Laceration | Firm uterus; bright red bleeding; history of rapid delivery or instrumentation; laceration visible on speculum exam | Extension to lower uterine segment; arterial bleeding |
| Vaginal or Perineal Laceration | Firm uterus; visible laceration; history of precipitous delivery, macrosomia, or instrumentation | Third or fourth degree tears; expanding hematoma | |
| Retained Placental Tissue | Incomplete placenta on inspection; prolonged third stage (>30 minutes); uterus fails to contract fully | Placenta accreta spectrum (especially with prior cesarean + placenta previa) | |
| Vaginal or Vulvar Hematoma | Perineal pain and pressure; visible or palpable swelling; shock disproportionate to visible blood loss | Rapidly expanding hematoma; hemodynamic instability | |
| UNCOMMON BUT SERIOUS (5-10%) | Uterine Rupture | History of prior cesarean or uterine surgery; sudden severe abdominal pain; abnormal fetal heart rate pattern prior to delivery; palpable defect in uterus | Intraperitoneal hemorrhage; shock; cessation of contractions |
| Uterine Inversion | Fundus not palpable abdominally; mass in vagina or at introitus; severe pain; often occurs with cord traction on fundal placenta | Neurogenic shock (bradycardia, hypotension); hemorrhage | |
| Placenta Accreta Spectrum | Placenta fails to separate; massive bleeding with attempted removal; history of prior cesarean with anterior placenta previa | Uncontrollable hemorrhage; may require hysterectomy | |
| Disseminated Intravascular Coagulation (DIC) | Diffuse oozing from multiple sites; blood fails to clot; associated with abruption, amniotic fluid embolism, sepsis, HELLP, IUFD | Bleeding from IV sites, gums; petechiae; worsening despite treatment of other causes | |
| Amniotic Fluid Embolism | Sudden cardiovascular collapse; respiratory distress; DIC; often during or immediately after delivery | Acute hypoxia; altered mental status; cardiac arrest; coagulopathy |
Secondary (Late) Postpartum Hemorrhage (24 Hours to 12 Weeks)
Step-by-Step Approach to Secondary PPH:
- Step 1: Assess hemodynamic stability — if unstable, resuscitate first
- Step 2: Consider the most common causes — retained products of conception (most common) and endometritis
- Step 3: Obtain pelvic ultrasound to evaluate for retained tissue
- Step 4: If infection suspected, obtain cultures and initiate antibiotics
- Step 5: Consider less common causes if initial workup negative (subinvolution, pseudoaneurysm, AVM)
| Probability | Condition | Typical Timing | Key Distinguishing Features |
|---|---|---|---|
| COMMON (50-60%) | Retained Products of Conception | 1-2 weeks postpartum | Bleeding after initial decrease; cramping; may have fever; ultrasound shows echogenic material in uterine cavity |
| COMMON (20-30%) | Endometritis | 2-10 days postpartum | Fever; uterine tenderness; foul-smelling lochia; may have retained products as well |
| LESS COMMON (10-15%) | Subinvolution of Placental Site | 2-6 weeks postpartum | Persistent or recurrent painless bleeding; enlarged, soft uterus; spiral arteries fail to thrombose normally |
| UNCOMMON (5%) | Uterine Artery Pseudoaneurysm | 1-8 weeks postpartum | Episodic severe bleeding; may occur after cesarean delivery; diagnosed by Doppler ultrasound or CT angiography |
| Arteriovenous Malformation (AVM) | Variable (may be acquired post-procedure) | Recurrent, often profuse bleeding; color Doppler shows turbulent flow; history of prior uterine instrumentation | |
| Inherited Bleeding Disorder | Throughout postpartum period | Personal or family history of bleeding; prolonged bleeding after procedures; may have been undiagnosed prior to pregnancy |
Anatomical Approach to PPH Causes
Uterine Corpus
Uterine atony
Retained placental tissue
Placenta accreta spectrum
Uterine rupture
Uterine inversion
Subinvolution of placental site
Endometritis
Lower Uterine Segment & Cervix
Cervical laceration
Extension of cesarean incision
Placenta previa/low-lying placenta
Lower segment atony
Vagina & Vulva
Vaginal laceration
Vaginal wall hematoma
Vulvar hematoma
Perineal laceration
Episiotomy complications
Systemic & Vascular
Coagulopathy (DIC, dilutional)
Inherited bleeding disorders
Anticoagulant effect
Uterine artery pseudoaneurysm
Arteriovenous malformation
Broad ligament hematoma
Drug-Induced or Drug-Associated Postpartum Hemorrhage
| Drug or Drug Class | Mechanism | Clinical Characteristics | Management Considerations |
|---|---|---|---|
| Magnesium Sulfate | Calcium antagonism → myometrial relaxation; inhibits acetylcholine release at neuromuscular junction | Used in pre-eclampsia prophylaxis; dose-dependent effect; may contribute to atony | Consider calcium gluconate if severe hypermagnesemia; may need higher doses of uterotonics |
| Oxytocin (prolonged use) | Oxytocin receptor desensitization with prolonged labor augmentation | Decreased response to postpartum oxytocin; atony despite “standard” doses | Use second-line uterotonics (carboprost, methylergonovine) earlier |
| Tocolytics (terbutaline, ritodrine) | Beta-2 agonist → myometrial relaxation | If administered close to delivery; may persist for hours | Effect wanes; may need aggressive uterotonic therapy initially |
| Calcium Channel Blockers (nifedipine) | Inhibits calcium influx → reduced myometrial contractility | Used as tocolytic; half-life 2-3 hours | Usually resolves by delivery; may compound atony risk |
| Volatile Anesthetics (sevoflurane, isoflurane) | Direct myometrial relaxation; dose-dependent effect | Used for general anesthesia cesarean; rapid onset atony | Reduce inspired concentration; switch to IV anesthesia if possible |
| Low-Molecular-Weight Heparin | Anticoagulation → impaired clot formation | Prophylactic or therapeutic dosing; timing relative to delivery critical | Protamine provides partial reversal; avoid neuraxial if recent dose |
| Aspirin | Irreversible platelet inhibition | Common for pre-eclampsia prevention; effect persists for platelet lifespan (7-10 days) | Platelet transfusion if severe bleeding; rarely clinically significant alone |
| Direct Oral Anticoagulants (rare in pregnancy) | Direct thrombin or factor Xa inhibition | Generally contraindicated in pregnancy; may encounter postpartum | Specific reversal agents available (idarucizumab, andexanet alfa) |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Immediate Next Step |
|---|---|---|
| Boggy, soft uterus + heavy bleeding | Uterine atony | Bimanual massage + oxytocin bolus + empty bladder |
| Firm uterus + continued bright red bleeding | Genital tract laceration | Thorough inspection with adequate exposure and lighting |
| Incomplete placenta on inspection | Retained placental fragments | Manual exploration ± ultrasound ± curettage |
| Placenta fails to separate after 30 minutes | Retained placenta ± placenta accreta | Manual removal; if abnormal adherence, suspect accreta spectrum |
| Prior cesarean + anterior placenta previa | Placenta accreta spectrum | Prepare for massive hemorrhage; multidisciplinary team |
| Fundus not palpable + mass in vagina | Uterine inversion | Do NOT remove placenta; immediate manual replacement |
| Prior cesarean + sudden pain + fetal distress | Uterine rupture | Emergency laparotomy |
| Diffuse oozing from multiple sites | Coagulopathy (DIC) | Send coagulation studies; initiate massive transfusion protocol |
| Shock disproportionate to visible blood loss | Concealed hemorrhage (broad ligament hematoma, intraperitoneal) | Urgent imaging or laparotomy |
| Sudden cardiovascular collapse + DIC | Amniotic fluid embolism | Aggressive resuscitation; multidisciplinary support; prepare for DIC |
| Late PPH + fever + uterine tenderness | Endometritis ± retained products | Antibiotics + ultrasound; consider surgical evacuation |
| Late PPH + episodic severe bleeding | Uterine artery pseudoaneurysm or AVM | Doppler ultrasound or CT angiography; interventional radiology consult |
Don’t Forget: Inherited Bleeding Disorders
Approximately 1-2% of women have an underlying inherited bleeding disorder, and pregnancy may be the first time this is unmasked. Consider screening for:
- von Willebrand Disease: Most common inherited bleeding disorder; levels increase in pregnancy but may fall rapidly postpartum, leading to delayed bleeding
- Factor XI Deficiency: Bleeding not proportional to factor level; may present with PPH
- Platelet Function Disorders: May be subtle; consider if unexplained bleeding with normal platelet count
- Hemophilia Carriers: May have reduced factor VIII or IX levels sufficient to cause bleeding
6. Diagnostic Investigations
A practical, stepwise approach to laboratory and imaging evaluation
In the acute setting of postpartum hemorrhage, investigations serve two purposes: (1) guiding resuscitation and transfusion therapy, and (2) identifying the underlying cause when not immediately apparent. Laboratory testing should never delay initial resuscitation or treatment of obvious causes. Point-of-care testing allows for rapid decision-making in the hemorrhaging patient.
Baseline Investigations for All Patients with PPH
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete Blood Count (CBC) | Assess degree of blood loss; baseline hemoglobin and platelet count | Hemoglobin drop (may lag behind acute blood loss); thrombocytopenia (<100,000 suggests DIC or dilution) | Initial hemoglobin may be normal despite significant hemorrhage due to hemoconcentration; serial CBCs more useful |
| Type and Screen / Crossmatch | Ensure blood availability for transfusion | Confirm blood type; detect unexpected antibodies | Should already be available from antenatal care; if not, send STAT; request crossmatch for 4-6 units if ongoing bleeding |
| Coagulation Studies (PT/INR, aPTT) | Detect coagulopathy; guide factor replacement | Prolonged PT/INR (>1.5) or aPTT (>1.5× normal) indicates significant factor depletion | Results may take 30-60 minutes; point-of-care testing faster if available |
| Fibrinogen Level | Critical predictor of severe PPH; guides cryoprecipitate use | Fibrinogen <200 mg/dL associated with severe PPH; <100 mg/dL indicates severe coagulopathy | Fibrinogen is the first factor to become critically depleted in PPH; target >200 mg/dL |
| Basic Metabolic Panel | Assess renal function and electrolytes | Elevated creatinine (acute kidney injury from hypoperfusion); hyperkalemia (from massive transfusion) | Acidosis (low bicarbonate) indicates tissue hypoperfusion |
| Arterial or Venous Blood Gas | Assess acid-base status and oxygenation | Metabolic acidosis (base deficit >6); lactate >4 mmol/L indicates poor perfusion | Lactate is an excellent marker of tissue hypoxia and resuscitation adequacy |
Point-of-Care Testing: Rapid Coagulation Assessment
Viscoelastic Testing (TEG/ROTEM)
Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) provide real-time, comprehensive assessment of coagulation at the bedside, with results available in 10-15 minutes. These tests evaluate the entire clotting process from initiation through clot strength to fibrinolysis.
- FIBTEM A5/A10 (ROTEM) or FF (TEG): Reflects fibrinogen contribution to clot strength; correlates with fibrinogen level
- EXTEM CT (ROTEM) or R-time (TEG): Reflects initiation of coagulation; prolonged values suggest factor deficiency
- Maximum Clot Firmness (MCF) or Maximum Amplitude (MA): Reflects overall clot strength; low values indicate need for platelets and/or fibrinogen
- Lysis indices: Detect hyperfibrinolysis; guides tranexamic acid use
Clinical utility: Allows goal-directed transfusion therapy; reduces unnecessary transfusion; identifies hyperfibrinolysis requiring antifibrinolytic therapy.
| Point-of-Care Test | What It Measures | Turnaround Time | Clinical Application |
|---|---|---|---|
| Hemoglobin (HemoCue) | Capillary or venous hemoglobin | 1-2 minutes | Rapid assessment of anemia; guides transfusion threshold |
| Blood Gas Analyzer | pH, lactate, base deficit, electrolytes, hemoglobin | 2-5 minutes | Comprehensive metabolic picture; lactate trends guide resuscitation |
| TEG/ROTEM | Complete coagulation profile | 10-15 minutes for initial results | Goal-directed blood component therapy; detect hyperfibrinolysis |
| Fibrinogen (Clauss method, point-of-care) | Functional fibrinogen level | 5-10 minutes | Guides cryoprecipitate or fibrinogen concentrate administration |
Targeted Investigations by Suspected Etiology
If Suspecting Retained Placental Tissue
First-Line: Bedside Ultrasound
- Transabdominal or transvaginal ultrasound: Evaluate endometrial cavity for echogenic material
- Endometrial thickness >10 mm: Suggests retained tissue (though not specific)
- Heterogeneous echogenic mass: Consistent with retained products
- Color Doppler: Vascularity within tissue suggests placental origin
Important Caveats
- Normal postpartum endometrium can appear echogenic
- Blood clots may mimic retained tissue
- Clinical correlation essential — do not rely on ultrasound alone
- If clinical suspicion high, manual exploration or surgical evacuation may be indicated regardless of imaging
If Suspecting Coagulopathy
Comprehensive Coagulation Panel
- PT/INR and aPTT: Assess extrinsic and intrinsic pathways
- Fibrinogen: Critical; first factor depleted in PPH
- D-dimer: Elevated in DIC, but non-specific in pregnancy
- Platelet count: Thrombocytopenia suggests DIC or dilution
- Peripheral blood smear: Schistocytes suggest DIC or TTP/HELLP
If Inherited Bleeding Disorder Suspected
- von Willebrand panel: vWF antigen, vWF activity (RiCof), factor VIII
- Factor assays: Factor VIII, IX, XI levels
- Platelet function testing: PFA-100 or platelet aggregation studies
- Note: These tests may be affected by acute hemorrhage; defer if possible until stable
If Suspecting Concealed Hemorrhage or Vascular Injury
Imaging Options
- Pelvic ultrasound with Doppler: May identify hematoma, pseudoaneurysm, or AVM
- CT with contrast (CT angiography): Identifies active extravasation, pseudoaneurysm, broad ligament hematoma
- MRI: Rarely needed acutely; may help characterize AVM or residual accreta tissue
When to Image
- Shock disproportionate to visible blood loss
- Dropping hemoglobin without obvious source
- Suspected broad ligament or retroperitoneal hematoma
- Recurrent episodic severe bleeding (pseudoaneurysm/AVM)
- Patient stable enough for transport to CT scanner
Laboratory Thresholds Guiding Transfusion
| Parameter | Critical Threshold | Target During Active Bleeding | Blood Product to Administer |
|---|---|---|---|
| Hemoglobin | <7 g/dL | >8 g/dL (some advocate >10 g/dL in ongoing hemorrhage) | Packed Red Blood Cells (PRBCs) |
| Fibrinogen | <200 mg/dL | >200 mg/dL (some advocate >250 mg/dL) | Cryoprecipitate (10 units raises fibrinogen ~50-70 mg/dL) or Fibrinogen concentrate |
| Platelets | <50,000/μL | >50,000/μL (>75,000/μL if ongoing bleeding) | Platelet transfusion (1 apheresis unit or 6-pack pooled platelets) |
| PT/INR | INR >1.5 | INR <1.5 | Fresh Frozen Plasma (FFP) — 15 mL/kg (~4-6 units) |
| aPTT | >1.5× normal | <1.5× normal | Fresh Frozen Plasma (FFP) |
Investigations for Secondary (Late) Postpartum Hemorrhage
| Investigation | Purpose | Expected Findings |
|---|---|---|
| Pelvic Ultrasound (transvaginal preferred) | Evaluate for retained products, endometrial pathology, vascular abnormalities | Echogenic endometrial mass (retained tissue); thickened endometrium; Doppler flow within mass (vascular) |
| Complete Blood Count | Assess anemia; detect leukocytosis suggesting infection | Low hemoglobin; elevated WBC (>15,000) suggests infection |
| C-Reactive Protein (CRP) | Marker of inflammation/infection | Elevated in endometritis |
| Blood and Endometrial Cultures | Identify causative organisms in endometritis | Polymicrobial infection common; may include anaerobes |
| β-hCG | Should be declining postpartum; persistent elevation may indicate retained products or GTD | Elevated β-hCG with retained products; very high levels concerning for GTD |
| Doppler Ultrasound or CT Angiography | Evaluate for pseudoaneurysm or AVM if episodic severe bleeding | Turbulent flow on Doppler; contrast extravasation or vascular malformation on CT |
| Coagulation Studies and Bleeding Disorder Workup | If recurrent or unexplained bleeding | von Willebrand panel, factor levels; consider hematology consultation |
Critical Principle: Treatment Before Test Results
In acute PPH, do not wait for laboratory results before initiating treatment:
- Tranexamic acid: Give within 3 hours of delivery — do not wait for coagulation results
- Empiric transfusion: If massive hemorrhage, initiate massive transfusion protocol (MTP) with empiric 1:1:1 ratio — do not wait for crossmatch (use O-negative or type-specific blood)
- Uterotonics: Administer immediately for suspected atony — do not wait for confirmation
- Surgical intervention: If source identified (laceration, retained placenta), proceed with treatment; investigations are secondary
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways for managing postpartum hemorrhage
Postpartum hemorrhage requires rapid, systematic decision-making. The key to successful management is early recognition, immediate activation of resources, and a stepwise escalation approach. Every institution should have a PPH protocol with clearly defined triggers, roles, and escalation pathways.
Step 1: Is This an Emergency? — Triage by Severity
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Cardiovascular collapse, unresponsive, pulseless | CARDIAC ARREST | Call code; initiate CPR; consider perimortem cesarean if undelivered; activate massive transfusion |
| Shock Index >1.0, altered mental status, blood loss >1500 mL | EMERGENT — Stage 3 PPH | Activate massive transfusion protocol; call for senior help; prepare for surgical intervention; bimanual compression |
| Blood loss 1000-1500 mL, tachycardia >100, Shock Index 0.9-1.0 | URGENT — Stage 2 PPH | Establish large-bore IV access ×2; type and crossmatch 4 units; uterotonics; identify cause; mobilize team |
| Blood loss 500-1000 mL, vital signs stable, Shock Index <0.9 | CONTROLLED — Stage 1 PPH | Fundal massage; uterotonics; empty bladder; monitor closely; identify cause; prepare for escalation |
Step 2: The “HAEMOSTASIS” Immediate Response
Use the “HAEMOSTASIS” algorithm for systematic initial management:
- H — Ask for Help: Call for additional staff, senior obstetrician, anesthesia, blood bank
- A — Assess (vital signs, blood loss) and Resuscitate: Two large-bore IVs, oxygen, fluid resuscitation
- E — Establish Etiology and Ensure Availability of Blood: Apply the Four T’s; send type and crossmatch
- M — Massage the Uterus: Bimanual compression; expel clots
- O — Oxytocin and Other Uterotonics: Administer in sequence
- S — Shift to Operating Room: If medical management fails, prepare for surgical intervention
- T — Tamponade (balloon/uterine packing): Consider intrauterine balloon if atony persists
- A — Apply Compression Sutures: B-Lynch or other compression sutures at laparotomy
- S — Systematic Pelvic Devascularization: Uterine artery ligation, internal iliac ligation
- I — Interventional Radiology: Uterine artery embolization if available and patient stable
- S — Subtotal/Total Hysterectomy: Definitive surgical management when other measures fail
Step 3: Cause-Specific Management Pathway
Algorithm A: Uterine Atony (Tone)
| Step | Intervention | Details | If No Response |
|---|---|---|---|
| 1 | Empty bladder + Uterine massage | Insert Foley catheter; bimanual compression; expel clots | Proceed to step 2 |
| 2 | First-line uterotonic: Oxytocin | 10-40 units in 500-1000 mL crystalloid IV; or 10 units IM | Proceed to step 3 |
| 3 | Second-line uterotonics | Methylergonovine 0.2 mg IM (avoid if hypertensive); Carboprost 250 mcg IM (avoid if asthmatic); Misoprostol 800-1000 mcg SL/PR | Proceed to step 4 |
| 4 | Tranexamic acid | 1 gram IV over 10 minutes; repeat if bleeding continues after 30 minutes | Proceed to step 5 |
| 5 | Intrauterine balloon tamponade | Bakri balloon or Foley catheter; inflate with 300-500 mL saline; maintain for 12-24 hours | Proceed to step 6 |
| 6 | Surgical intervention | B-Lynch compression suture; uterine artery ligation; internal iliac artery ligation | Proceed to step 7 |
| 7 | Hysterectomy | Definitive treatment; subtotal often faster in emergency; do not delay if life-threatening | Damage control surgery; ICU |
Algorithm B: Genital Tract Trauma
| Clinical Scenario | Action | Key Points |
|---|---|---|
| Perineal/vaginal laceration | Surgical repair with adequate anesthesia and visualization | Ensure apex of laceration is identified; use absorbable suture; inspect for hematoma |
| Cervical laceration | Repair with figure-of-eight sutures; ring forceps for exposure | May extend to lower uterine segment; ensure hemostasis at apex |
| Expanding hematoma | Incision and drainage; ligate bleeding vessels; pack if needed | May require laparotomy if broad ligament or retroperitoneal involvement |
| Uterine rupture | Emergency laparotomy; repair vs. hysterectomy based on extent | Repair if edges viable and patient stable; hysterectomy if extensive or unstable |
| Uterine inversion | Immediate manual replacement; uterine relaxants may help; laparotomy if manual fails | Do NOT remove attached placenta before replacement; resuscitate aggressively |
Algorithm C: Retained Tissue
| Clinical Scenario | Action | Key Points |
|---|---|---|
| Retained placenta (>30 minutes) | Manual removal under adequate anesthesia; controlled cord traction | Establish IV access; give uterotonics after removal; antibiotic prophylaxis |
| Retained placental fragments | Manual exploration; gentle curettage with large blunt curette or suction | Avoid vigorous curettage (perforation risk); ultrasound guidance helpful |
| Suspected placenta accreta (fails to separate) | STOP manual removal attempts; call for help; prepare for hysterectomy | Forced removal causes massive hemorrhage; may leave placenta in situ with methotrexate in selected cases |
Algorithm D: Coagulopathy (Thrombin)
| Clinical Scenario | Action | Key Points |
|---|---|---|
| Suspected DIC | Treat underlying cause; massive transfusion protocol (1:1:1); fibrinogen replacement | Target fibrinogen >200 mg/dL; avoid hypothermia; consider recombinant factor VIIa as last resort |
| Dilutional coagulopathy | Balanced transfusion; avoid crystalloid-heavy resuscitation | 1:1:1 ratio of PRBC:FFP:platelets; early fibrinogen replacement |
| Known inherited bleeding disorder | Factor replacement specific to deficiency; hematology consultation | vWD: desmopressin or vWF concentrate; Hemophilia carriers: factor VIII/IX concentrate |
| Anticoagulant effect | Reversal agents: protamine for heparin; vitamin K/FFP/PCC for warfarin; specific reversal for DOACs | Consult pharmacy/hematology for dosing; transfuse blood products as needed |
Massive Transfusion Protocol Activation
When to Activate MTP
- Estimated blood loss >1500 mL with ongoing bleeding
- Shock Index >1.0
- Anticipated need for >4 units PRBCs
- Hemodynamic instability despite initial resuscitation
- Clinical judgment: “This patient is bleeding to death”
Initial MTP pack typically contains: 6 units PRBCs, 6 units FFP, 1 apheresis platelet unit (or 6-pack pooled), 10 units cryoprecipitate. Ratio goal is 1:1:1.
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Oxytocin not working after 2-3 minutes | Add second-line uterotonic (methylergonovine or carboprost) | Continue bimanual compression; reassess in 2-3 minutes; consider balloon |
| Patient hypertensive — cannot give methylergonovine | Use carboprost 250 mcg IM or misoprostol 800-1000 mcg SL/PR | Avoid ergot alkaloids entirely; monitor blood pressure |
| Patient asthmatic — cannot give carboprost | Use methylergonovine 0.2 mg IM (if not hypertensive) or misoprostol | Prostaglandin F2α contraindicated; misoprostol is safe in asthma |
| All uterotonics failing | Insert intrauterine balloon; give tranexamic acid if not already given | Prepare for operating room; call senior help; surgical intervention likely needed |
| Balloon tamponade failing | Proceed to laparotomy; compression sutures (B-Lynch) | If B-Lynch fails → uterine artery ligation → hysterectomy |
| No blood available yet but patient exsanguinating | Give O-negative blood (universal donor); do not wait for crossmatch | Switch to type-specific blood when available; continue MTP |
| Fibrinogen critically low (<100 mg/dL) | Give cryoprecipitate 10 units or fibrinogen concentrate 2-4 grams | Recheck fibrinogen in 30-60 minutes; repeat if still low |
| Bleeding controlled but patient remains hypotensive | Continue resuscitation; consider other causes (amniotic fluid embolism, anaphylaxis, sepsis) | Assess for concealed hemorrhage; consider vasopressors if fluid-refractory |
| Secondary PPH — patient presents from home | Assess hemodynamic stability; obtain IV access; send labs; pelvic ultrasound | Antibiotics if infection suspected; surgical evacuation if retained products confirmed |
Troubleshooting Refractory Postpartum Hemorrhage
Ask These Questions When Bleeding Continues
- Have all Four T’s been addressed? Re-evaluate for each cause systematically
- Is there concealed hemorrhage? Broad ligament hematoma, intraperitoneal bleeding may not be visible
- Is coagulopathy developing or worsening? Check TEG/ROTEM or send repeat coagulation studies
- Is fibrinogen adequate? Most critical factor — target >200 mg/dL
- Is the patient hypothermic? Hypothermia impairs coagulation — actively warm
- Is the patient acidotic? Acidosis impairs coagulation — optimize resuscitation
- Has tranexamic acid been given? Give within 3 hours of delivery
- Is surgical intervention being delayed inappropriately? Do not persist with failing medical management
- Should interventional radiology be involved? Uterine artery embolization if available and patient stable
- Is hysterectomy the right decision now? Do not delay life-saving surgery to preserve fertility
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
The Four T’s cover everything: Systematically work through Tone, Trauma, Tissue, and Thrombin — you will identify the cause in virtually every case. Uterine atony (Tone) accounts for 70-80% of PPH.
Shock Index is more sensitive than blood pressure: Calculate Heart Rate ÷ Systolic BP. A Shock Index >0.9 in a postpartum patient should trigger concern; >1.0 is associated with need for massive transfusion. Don’t be falsely reassured by “normal” blood pressure.
Give tranexamic acid early: The WOMAN trial showed a significant mortality reduction when tranexamic acid was given within 3 hours of delivery. Don’t wait for coagulation results — give 1 gram IV empirically in significant PPH.
Fibrinogen is the first factor to fall: Fibrinogen <200 mg/dL is a strong predictor of severe PPH progression. Replace early with cryoprecipitate (10 units) or fibrinogen concentrate (2-4 grams). Don’t wait for “critical” levels.
Quantify blood loss: Visual estimation underestimates blood loss by 30-50%. Use calibrated drapes and weigh blood-soaked materials (1 gram = 1 mL blood). Quantitative blood loss measurement improves early PPH recognition.
Empty the bladder first: A full bladder prevents effective uterine contraction. Insert a Foley catheter immediately in any PPH — this simple intervention is often overlooked and can be therapeutic.
Bimanual compression buys time: While waiting for uterotonics to work, blood to arrive, or the operating room to be ready, effective bimanual uterine compression can be life-saving. Maintain compression until definitive treatment is achieved.
Anticipate PPH in high-risk patients: Previous PPH is the strongest risk factor. For high-risk patients, ensure blood is available, IV access is established, and the team is prepared before delivery.
Critical Pitfalls to Avoid
Being falsely reassured by “normal” vital signs: Pregnant women have expanded blood volume and can lose 1500 mL before showing significant vital sign changes. A “normal” blood pressure in an actively bleeding patient is NOT reassuring — calculate the Shock Index instead.
Attributing all bleeding to atony without examining for trauma: If the uterus is firm but bleeding continues, atony is NOT the cause. You must perform a thorough inspection of the cervix and vagina — lacerations can cause life-threatening hemorrhage.
Delaying transfusion waiting for laboratory results: In massive hemorrhage, initiate empiric transfusion with O-negative blood and massive transfusion protocol. Waiting for crossmatch or hemoglobin results in a critically bleeding patient can be fatal.
Resuscitating with crystalloid alone: Large-volume crystalloid resuscitation causes dilutional coagulopathy and worsens bleeding. Use balanced transfusion (1:1:1 ratio) early. Crystalloids should not be the primary resuscitation fluid in massive PPH.
Persisting with failing medical management too long: If uterotonics and balloon tamponade are not working, proceed to surgical intervention. Delays in moving to laparotomy and hysterectomy cost lives. Do not sacrifice the patient to save the uterus.
Attempting forceful manual removal of an adherent placenta: If the placenta does not separate with gentle traction and the cleavage plane is not found, STOP. This may be placenta accreta, and forceful removal will cause catastrophic hemorrhage. Call for help and prepare for hysterectomy.
Removing the placenta before replacing an inverted uterus: In uterine inversion, the attached placenta provides some tamponade. Removing it before replacement dramatically worsens bleeding. Replace the uterus first, then manage the placenta.
Forgetting to warm the patient and blood products: Hypothermia severely impairs coagulation. Use blood warmers, warm IV fluids, forced-air warming blankets, and increase room temperature. The “lethal triad” of hypothermia, acidosis, and coagulopathy is preventable.
Key Takeaways
- Postpartum hemorrhage is defined as blood loss ≥1000 mL or bleeding with signs of hypovolemia within 24 hours of delivery, regardless of delivery route.
- The “Four T’s” (Tone, Trauma, Tissue, Thrombin) provide a systematic framework for identifying the cause — uterine atony accounts for 70-80% of cases.
- Approximately 40% of PPH occurs in women with no identifiable risk factors — every delivery team must be prepared.
- The Shock Index (HR/SBP) is more sensitive than individual vital signs; a Shock Index >1.0 indicates severe hemorrhage requiring aggressive intervention.
- Visual estimation underestimates blood loss by 30-50%; quantitative blood loss measurement should be standard practice.
- Tranexamic acid reduces mortality when given within 3 hours of delivery — give early, don’t wait for coagulation results.
- Fibrinogen is the first coagulation factor to become critically depleted; maintain fibrinogen >200 mg/dL with cryoprecipitate or fibrinogen concentrate.
- The “firm uterus with ongoing bleeding” scenario requires systematic evaluation for trauma, retained tissue, or coagulopathy — do not keep giving uterotonics.
- Massive transfusion protocol with 1:1:1 ratio should be activated early in severe PPH; avoid crystalloid-heavy resuscitation.
- Prevention of the “lethal triad” (hypothermia, acidosis, coagulopathy) is as important as surgical control of bleeding.
- When medical management fails, proceed promptly to surgical intervention — do not delay hysterectomy when it is needed to save the patient’s life.
- Multidisciplinary teamwork with clear communication, defined roles, and rehearsed protocols improves outcomes in PPH.
Quick Reference Algorithm
Systematic Approach to Postpartum Hemorrhage:
- RECOGNIZE: Blood loss ≥1000 mL or any bleeding with vital sign changes → Activate PPH protocol
- CALL FOR HELP: Notify senior obstetrician, anesthesia, nursing support, blood bank
- RESUSCITATE: Two large-bore IVs, oxygen, type and crossmatch, initiate transfusion if severe
- IDENTIFY CAUSE: Apply the Four T’s — Tone (massage uterus), Trauma (inspect genital tract), Tissue (check placenta), Thrombin (assess for coagulopathy)
- TREAT CAUSE: Uterotonics for atony; repair lacerations; remove retained tissue; replace clotting factors
- GIVE TXA: Tranexamic acid 1 gram IV within 3 hours of delivery
- ESCALATE: If bleeding continues → balloon tamponade → surgical intervention → hysterectomy
- PREVENT TRIAD: Warm the patient, correct acidosis, maintain coagulation with balanced transfusion
- MONITOR: Serial vital signs, Shock Index, urine output, laboratory values (hemoglobin, fibrinogen, coagulation)
- DEBRIEF: After stabilization, conduct team debrief; document thoroughly; provide patient support